Neoantigen-specific immunotherapy

Clinical trials for Neoantigen-specific immunotherapy explained in plain language.

Never miss a new study

Get alerted when new Neoantigen-specific immunotherapy trials appear

Sign up with your email to follow new studies for Neoantigen-specific immunotherapy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Custom-Made cancer vaccine shows promise in early trial

Vaccine Recruiting now

This study tests a personalized vaccine made from each patient's unique tumor mutations. The vaccine is designed to train the immune system to attack the cancer. Ten adults with advanced or high-risk solid tumors will receive the vaccine along with immune-boosting drugs. The goal…

Matched conditions: NEOANTIGEN-SPECIFIC IMMUNOTHERAPY

Phase 1/2 • Sponsor: Seqker Biosciences, Inc. • Aim: Vaccine

Last updated Jul 26, 2026 00:00 UTC

Neoantigen-specific immunotherapy

Get alerted when new Neoantigen-specific immunotherapy trials appear

Custom-Made cancer vaccine shows promise in early trial